Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

More people may be at risk for developing COPD due to exposure to environmental irritants, such as heat waves and air ...

Increased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic ...

If you have chronic obstructive pulmonary disease (COPD), your airways may be inflamed. It may be hard to take deep breaths and get enough oxygen.

Increased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic obstructive pulmonary disease (COPD), according to a new study.

The findings, published in The Lancet Respiratory Medicine, suggest that dupilumab, when used alongside standard triple ...

Chronic Obstructive Pulmonary Disease (COPD) Market. COPD market grows with rising disease prevalence, innovation in therapies, and increasing global healt ...

It had been hoped that RA patients might actually benefit more from these drugs, known as immune checkpoint inhibitors (ICIs) ...

Researchers sought to determine the relationship among hospitalization for COPD exacerbation, AF burden, and risk for subsequent stroke.

Nottinghamshire Healthcare’s community respiratory nurses are excited to pilot a brand new programme for patients with newly ...

Discover Verona Pharma's Q1 2025 earnings report, featuring Ohtuvayre's rapid adoption, sales milestones, and global expansion.

As Sanofi anticipates sales of immunotherapy juggernaut Dupixent reaching a major $22 billion by the end of the decade, ...